Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Bates

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic RecoveryJohn A Kink, Matthew H Forsberg, Sofiya Reshetylo, et al.
Leukemia|April 17, 2026
PRMT5 inhibition sensitizes B-cell lymphoma cells to ferroptosisYunxia Liu, Ruoyu Chen, Xiaoyue Gao, et al.
Cell Reports. Medicine|March 30, 2024
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphomaNguyet-Minh Hoang, Yunxia Liu, Paul D Bates, et al.
Molecular Cancer Research : MCR|May 13, 2021
EGR1 Addiction in Diffuse Large B-cell LymphomaShuichi Kimpara, Li Lu, Nguyet M Hoang, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha Quamine, Nicholas R Mohrdieck, Chloe A King, et al.
Leukemia|May 25, 2019
PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cellsFen Zhu, Hui Guo, Paul D Bates, et al.
Blood|September 22, 2023
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphomaYunxia Liu, Shuichi Kimpara, Nguyet M Hoang, et al.
Journal for Immunotherapy of Cancer|December 12, 2025
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha E Quamine, Evan L Dray, Nicholas R Mohrdieck, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcomaMonica M Cho, Longzhen Song, Aicha E Quamine, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic RecoveryJohn A Kink, Matthew H Forsberg, Sofiya Reshetylo, et al.
Leukemia|April 17, 2026
PRMT5 inhibition sensitizes B-cell lymphoma cells to ferroptosisYunxia Liu, Ruoyu Chen, Xiaoyue Gao, et al.
Cell Reports. Medicine|March 30, 2024
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphomaNguyet-Minh Hoang, Yunxia Liu, Paul D Bates, et al.
Molecular Cancer Research : MCR|May 13, 2021
EGR1 Addiction in Diffuse Large B-cell LymphomaShuichi Kimpara, Li Lu, Nguyet M Hoang, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha Quamine, Nicholas R Mohrdieck, Chloe A King, et al.
Leukemia|May 25, 2019
PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cellsFen Zhu, Hui Guo, Paul D Bates, et al.
Blood|September 22, 2023
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphomaYunxia Liu, Shuichi Kimpara, Nguyet M Hoang, et al.
Journal for Immunotherapy of Cancer|December 12, 2025
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha E Quamine, Evan L Dray, Nicholas R Mohrdieck, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcomaMonica M Cho, Longzhen Song, Aicha E Quamine, et al.
Pageof 2